AKRO: Akero Therapeutics Company Short-Term Debt

Symbol and logo of brand Akero Therapeutics (AKRO)

How does full production outsourcing affect the financial burden of Akero Therapeutics (AKRO)? Short-term debt fluctuations on the GURU.Markets system chart provide the answer, where the 0.00 indicator determines the parameter status. Andrew Cheng and his team are successfully competing for leadership in steatohepatitis therapy, while a stable research staff is expanding through the recruitment of new metabolism experts.

AKRO (Akero Therapeutics, Inc.) Company Short-Term Debts history from 07/04/2022 to 12/20/2025

AKRO (Akero Corp): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart Akero|AKRO - Fair Value Consensus
- market capitalization information:
Market Value Akero|AKRO - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Akero Therapeutics|AKRO - Book Capitalization|Market Cap to Net Assets Ratio akerotx.com|AKRO - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Akero Therapeutics|AKRO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Akero Therapeutics|AKRO - Company Cumulative Debt|Debt to Book Value Akero|AKRO - Amount of Long-Term Liabilities|Company Short-Term Debts Akero Therapeutics|Quick Ratio akerotx.com
- net income and valuation multiples indicators:
AKRO - Company Net Income
Basic company analysis:Akero - AKRO
Mass-produced product of Akero Corp

For the biotech sector company Akero Therapeutics (AKRO), which depends on clinical trial outcomes, the dynamics of short-term credit obligations on GURU.Markets serve as an indicator of financial stability during periods of zero revenue. This metric aggregates all debts with a maturity of up to one year, allowing for an assessment of liquidity risk and the efficiency of debt capital management without compromising the margins of future developments.

Who Akero Therapeutics competes with

ASND - Company Short-Term Debt|Company Short-Term Loans and Borrowings MDGL (Madrigal Pharmaceuticals Inc)|Corcept (CORT) - Company Short-Term Debt|Company Current Liabilities Rhythm Corp|MTSR (Metsera Inc) - Company Short-Term Debts|Company Short-Term Debts moonlaketx.com|Company Current Liabilities CRNX (Crinetics)|NAMS (NewAmsterdam Pharma Company) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Soleno SLNO|FOLD - Company Current Liabilities|89bio, Inc. - Company Short-Term Debts|Short-Term Debt agios.com|GPCR (Structure Therapeutics Inc.) - Company Current Liabilities|MDXG: Amount of Current Liabilities|RZLT (Rezolute Corp) - Company Short-Term Debts|Company Short-Term Debts Lexicon Corp|Company Short-Term Debts MBX|Company Short-Term Debt ALT (altimmune.com)|Company Short-Term Debt Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. (SGMT) - Short-Term Debt|BIOA - Company Short-Term Debt|BMEA: Company Short-Term Debt|QNCX: Company Short-Term Debts|GUTS - Short-Term Debt Volume|Company Short-Term Debt vTv Therapeutics, Inc.|Agape ATP Corp. (ATPC) - Short-Term Debt Volume|Company Short-Term Debt Pluri Inc. (PLUR)|Company Current Liabilities synlogictx.com SYBX|Company Short-Term Debts LPCN (Lipocine Inc.)|Company Short-Term Debts Matinas BioPharma Holdings, Inc. MTNB|SPRB - Company Short-Term Debt|GLTO - Company Short-Term Debts|CTCX: Company Short-Term Debts|Short-Term Debt Lumos Therapeutics (LUMO)|Company Short-Term Debt Organovo Holdings, Inc.|RDUS: Company Short-Term Loans and Borrowings